Mani Foroohar

Mani Foroohar

Analyst-Equity en
Leerink Partners LLC
.
Finance
Consumer Services

Perfil

Dr. Mani Foroohar is a Senior Managing Director of Genetic Medicines at Leerink Partners LLC.
He is also a Senior Research Analyst within the Therapeutics team focusing on Genetic Medicines.
Dr. Foroohar joins Leerink from Aptigon Capital, a Citadel Company, where he most recently was a Therapeutics Analyst focused on U.S.
and EU biotechnology, major pharmaceuticals and specialty pharmaceuticals sectors.
Prior to Aptigon, he was an Analyst at Green Owl Capital Management and an Assistant Vice President of Equity Research at Barclays.
In 2013, he co-founded Cellanyx Diagnostics, a company developing a proprietary live tumor cell, phenotypic platform for precision risk stratification in cancer to inform clinical treatment decision making.
Dr. Foroohar holds an M.D.
from Stanford, where he was a Howard Hughes Medical Institute Research Fellow in the Department of Genetics, M.B.A. from Columbia, and a B.S.
from UCLA.

Cargos activos de Mani Foroohar

EmpresasCargoInicio
Analyst-Equity 01/05/2018

Antiguos cargos conocidos de Mani Foroohar.

EmpresasCargoFin
Analyst-Equity 01/12/2014
Analyst-Equity -
Ver el detalle de la experiencia de Mani Foroohar.

Formación de Mani Foroohar.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

99

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas6

Finance

Finance

Consumer Services

Finance

Consumer Services

Consumer Services